共 15 条
[1]
[2]
[3]
[4]
[5]
Non-Alcoholic Fatty Liver Disease (NAFLD): New challenge for general practitioners and important burden for health authorities?[J] Mohamed H. Ahmed;Emmanuel O. Abu;Christopher D. Byrne Primary Care Diabetes 2010,
[6]
Obesity-Associated Liver Disease[J] Giulio Marchesini;Simona Moscatiello;Silvia Di Domizio;Gabriele Forlani The Journal of Clinical Endocrinology & Metabolism 2008,
[7]
In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease[J] Anna Wieckowska;Nizar N. Zein;Lisa M. Yerian;A. Rocio Lopez;Arthur J. McCullough;Ariel E. Feldstein Hepatology 2006,
[8]
Pathology of nonalcoholic steatohepatitis[J] Elizabeth M. Brunt Hepatology Research 2005,
[9]
Non-alcoholic Steatohepatitis (NASH) and Hepatocellular Carcinoma[J] Antonio Cuadrado;Aitor Orive;Covadonga García-Suárez;Agustín Domínguez;Jose Carlos Fernández-Escalante;Javier Crespo;Fernando Pons-Romero Obesity Surgery 2005,
[10]
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis[J] Ariel E Feldstein;Ali Canbay;Paul Angulo;Makiko Taniai;Lawrence J Burgart;Keith D Lindor;Gregory J Gores Gastroenterology 2003,

